
Sue-Ann Woo
Advertisement
Articles by Sue-Ann Woo

Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Tarlatamab Plus Chemo/IO Regimens Are Safe, Elicit Responses in ES-SCLC
2
Frontline Alectinib Upholds OS Benefit in Advanced ALK+ NSCLC
3
Tarlatamab Improves Survival Vs Chemotherapy in Second-Line SCLC Subgroups
4
Episode 16: Anticipated ESMO 2025 Data That May Change GU Oncology
5